Suchergebnisse - "Rao, Martin"

PubPharm (63)

11

CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors

enthalten in: Scientific reports | 2018

von Meng, Q. | Valentini, D. | Rao, M. | +2

12

The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer

enthalten in: Immunology | 2018

von Luo, X. | Meng, Q. | Rao, M. | +4

13

Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme

enthalten in: EBioMedicine | 2018

von Zhenjiang, L. | Rao, M. | Luo, X. | +11

14

Tuberculosis : progress and advances in development of new drugs, treatment regimens, and host-directed therapies

enthalten in: The Lancet. Infectious diseases | 2018

von Tiberi, S. | du Plessis, N. | Walzl, G. | +11

ErratumIn: Lancet Infect Dis. 2018 Apr 27;:. - PMID 29709349

15

Epstein-Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer

enthalten in: Journal of translational medicine | 2018

von Liu, Z. | Poiret, T. | Meng, Q. | +7

16

Epstein–Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer

enthalten in: Journal of translational medicine | 2018

von Liu, Z. | Poiret, T. | Meng, Q. | +7

17

Epstein–Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer

enthalten in: Journal of translational medicine | 2018

von Liu, Z. | Poiret, T. | Meng, Q. | +7

18

Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responses

enthalten in: Oncotarget | 2018

von Meng, Q. | Valentini, D. | Rao, M. | +9

19

B cells or T cells in TB : a continuing conundrum

enthalten in: The Lancet. Respiratory medicine | 2018

von Maeurer, M. | Rao, M. | Zumla, A.

CommentOn: Lancet Respir Med. 2018 Apr;6(4):287-298. - PMID 29595510

20

Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2018

von Rao, M. | Valentini, D. | Zumla, A. | +1